Valerie Auffray has joined Apposite Capital, a healthcare-focused investment firm based in
Apposite Capital LLP, the investment firm exclusively focused on healthcare, announced today that it has appointed Valerie Auffray as Investor Relations Manager. Valerie will manage the firm's overall investor relations and communications activities as well as its fundraising efforts.
Valerie has over seven years experience in providing PR and IR consultancy to biotech and healthcare companies. Prior to joining Apposite Capital, Valerie was an Associate Director at Citigate Dewe Rogerson, a leading internal communications consultancy firm. She worked with a number of biotech companies at all stages of development across
David Porter, Managing Partner, Apposite Capital, commented: “I am very pleased to welcome Valerie to the team. Her expertise will be invaluable and will significantly enhance our investor relations, communications and fundraising functions, which are critical in supporting the continued success of the firm.”
Commenting on her appointment, Valerie Auffray said: “Apposite has built an excellent reputation investing in Healthcare services and Life sciences companies globally. I was very impressed by the team track record and the Fund already generating a positive net IRR. I am delighted to be joining this talented and experienced team.”
– Ends –
About Apposite Capital
Apposite Capital is an independent investment firm focused exclusively on Healthcare. The firm primarily invests in private companies involved in healthcare services and life sciences.
Apposite has an in-depth sector knowledge covering all aspects of the healthcare industry globally, with a unique unrivalled reach to
Apposite has built a high quality portfolio of companies in the
Created in 2006, Apposite has over $200 million of committed capital under management and is based in London, UK.